Related Experiment Videos
Ligand dependency of 5-hydroxytryptamine 2C receptor internalization
Brian D Schlag1, Zhuangwei Lou, Myles Fennell
1Neuroscience Discovery Research, Wyeth Research, CN 8000, Princeton, NJ 08543, USA.
The Journal of Pharmacology and Experimental Therapeutics
|April 29, 2004
Summary
Agonist and partial agonist binding causes 5-hydroxytryptamine (5-HT)2C receptor internalization, a process crucial for receptor desensitization. Inverse agonists and neutral antagonists do not induce this internalization.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- G protein-coupled receptors (GPCRs) undergo agonist-induced internalization, a mechanism linked to receptor desensitization.
- The 5-hydroxytryptamine (5-HT)2C receptor, a specific type of GPCR, has been shown to internalize upon agonist exposure.
Purpose of the Study:
- To investigate the internalization patterns of the 5-HT2C receptor in response to various ligands.
- To determine if different classes of 5-HT2C receptor modulators (agonists, partial agonists, inverse agonists, antagonists) induce receptor internalization.
Main Methods:
- Utilized a human embryonic kidney cell line expressing a green fluorescent protein (GFP)-tagged 5-HT2C receptor (VSV isoform).
- Employed an automated fluorescence imaging system (Arrayscan) to quantify receptor internalization.
- Assessed receptor function using intracellular Ca2+ measurements via a flourometric imaging plate reader.
- Confirmed internalization patterns using confocal microscopy.
Main Results:
- All three tested agonists induced dose-dependent internalization of the 5-HT2C receptor.
- Partial agonists resulted in approximately 50% less internalization compared to full agonists.
- Inverse agonists and neutral antagonists did not induce any significant internalization of the 5-HT2C receptor.
Conclusions:
- The 5-HT2C receptor undergoes internalization when incubated with agonists and partial agonists.
- Internalization of the 5-HT2C receptor is ligand-dependent, with inverse agonists and neutral antagonists failing to trigger this process.
- These findings contribute to understanding the complex mechanisms of GPCR regulation and desensitization.